Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function

Reina-Couto, 2014, Impaired resolution of inflammation in human chronic heart failure, Eur J Clin Invest, 44, 527, 10.1111/eci.12265 Kain, 2014, Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction, Basic Res Cardiol, 109, 444, 10.1007/s00395-014-0444-7 Serhan, 2014, Pro-resolving lipid mediators are leads for resolution physiology, Nature, 510, 92, 10.1038/nature13479 Saito, 2004, Inhibition of COX pathway in experimental myocardial infarction, J Mol Cell Cardiol, 37, 71, 10.1016/j.yjmcc.2004.04.002 Kimmel, 2005, Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction, Ann Intern Med, 142, 157, 10.7326/0003-4819-142-3-200502010-00005 Mann, 2004, Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL), Circulation, 109, 1594, 10.1161/01.CIR.0000124490.27666.B2 Zhang, 2014, Phagocyte–myocyte interactions and consequences during hypoxic wound healing, Cell Immunol, 29, 65, 10.1016/j.cellimm.2014.04.006 Lopez, 2015, Obesity superimposed on aging magnifies inflammation and delays the resolving response following myocardial infarction, Am J Physiol Heart Circ Physiol, 308, H269, 10.1152/ajpheart.00604.2014 Halade, 2010, Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupus-prone mice, J Immunol, 184, 5280, 10.4049/jimmunol.0903282 Zhang, 2012, Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids, Annu Rev Nutr, 32, 203, 10.1146/annurev-nutr-071811-150726 Tang, 2014, Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury, J Immunol, 193, 3769, 10.4049/jimmunol.1400942 Chiang, 2012, Infection regulates pro-resolving mediators that lower antibiotic requirements, Nature, 484, 524, 10.1038/nature11042 Rius, 2014, Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis, FASEB J Off Publ Fed Am Soc Exp Biol, 28, 836 Sun, 2007, Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation, J Biol Chem, 282, 9323, 10.1074/jbc.M609212200 Koning, 1999, Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells, Biochim Biophys Acta Biomembr, 1420, 153, 10.1016/S0005-2736(99)00091-7 Zhao, 2005, Light scattering studies of stereocomplex formation of stereoregular poly(methyl methacrylate) in solutions, Eur Polym J, 41, 447, 10.1016/j.eurpolymj.2004.10.031 Halade, 2013, Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice, Am J Physiol Heart Circ Physiol, 305, H1830, 10.1152/ajpheart.00224.2013 Colas, 2014, Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue, Am J Physiol Cell Physiol, 307, C39, 10.1152/ajpcell.00024.2014 Zamilpa, 2012, Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction, J Mol Cell Cardiol, 53, 599, 10.1016/j.yjmcc.2012.07.017 Frangogiannis, 2012, Regulation of the inflammatory response in cardiac repair, Circ Res, 110, 159, 10.1161/CIRCRESAHA.111.243162 Norling, 2012, Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions, Arterioscler Thromb Vasc Biol, 32, 1970, 10.1161/ATVBAHA.112.249508 Krishnamoorthy, 2010, Resolvin D1 binds human phagocytes with evidence for proresolving receptors, Proc Natl Acad Sci U S A, 107, 1660, 10.1073/pnas.0907342107 Ismahil, 2014, Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis, Circ Res, 114, 266, 10.1161/CIRCRESAHA.113.301720 Emami, 2015, Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans, JACC Cardiovasc Imaging, 2, 121, 10.1016/j.jcmg.2014.10.009 Kim, 2014, Metabolic activity of the spleen and bone marrow in patients with acute myocardial infarction evaluated by 18F-fluorodeoxyglucose positron emission tomographic imaging, Circ Cardiovasc Imaging, 7, 454, 10.1161/CIRCIMAGING.113.001093 Puga, 2012, B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen, Nat Immunol, 13, 170, 10.1038/ni.2194 McCauley, 2014, Cutting edge: parathyroid hormone facilitates macrophage efferocytosis in bone marrow via proresolving mediators resolvin D1 and resolvin D2, J Immunol, 193, 26, 10.4049/jimmunol.1301945 Blomer, 2013, 5-Lipoxygenase facilitates healing after myocardial infarction, Basic Res Cardiol, 108, 367, 10.1007/s00395-013-0367-8 Maskrey, 2011, Mechanisms of resolution of inflammation: a focus on cardiovascular disease, Arterioscler Thromb Vasc Biol, 31, 1001, 10.1161/ATVBAHA.110.213850 Ji, 2011, Emerging roles of resolvins in the resolution of inflammation and pain, Trends Neurosci, 34, 599, 10.1016/j.tins.2011.08.005 Dutta, 2012, Myocardial infarction accelerates atherosclerosis, Nature, 487, 325, 10.1038/nature11260 Ismahil, 2013, Cardiac immune cell remodeling after myocardial infarction, J Mol Cell Cardiol, 62, 142, 10.1016/j.yjmcc.2013.05.017 Leuschner, 2012, Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis, J Exp Med, 209, 123, 10.1084/jem.20111009 Ramon, 2012, Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells, J Immunol, 189, 1036, 10.4049/jimmunol.1103483 Tang, 2013, Proresolution therapy for the treatment of delayed healing of diabetic wounds, Diabetes, 62, 618, 10.2337/db12-0684 Dalli, 2013, Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor, J Immunol, 190, 6478, 10.4049/jimmunol.1203000 Serhan, 2005, Resolution of inflammation: the beginning programs the end, Nat Immunol, 6, 1191, 10.1038/ni1276 Colotta, 1992, Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products, Blood, 80, 2012, 10.1182/blood.V80.8.2012.2012 Wang, 2009, The signaling mechanisms underlying cell polarity and chemotaxis, Cold Spring Harb Perspect Biol, 1, a002980, 10.1101/cshperspect.a002980 Huebener, 2008, CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response, J Immunol, 180, 2625, 10.4049/jimmunol.180.4.2625 Yabluchanskiy, 2013, Left ventricular remodeling: one small step for the extracellular matrix will translate to a giant leap for the myocardium, Congest Heart Fail, 19, E5, 10.1111/chf.12023 Cheng, 2002, Role of prostacyclin in the cardiovascular response to thromboxane A2, Science, 296, 539, 10.1126/science.1068711 Fredman, 2014, Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway, Proc Natl Acad Sci U S A, 111, 14530, 10.1073/pnas.1410851111